Biotech News

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Charles River (CRL)Charles River2026-06-18 12:00 ESTFDA / regulatory

Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies WILMINGTON, Mass. --(BUSINESS WIRE)--Jun. 18, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly

Charles River

Preclinical Research Services Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development. Research Models and Services The company supplies research models and related services used in basic research, target validation and...

Recent company news

CRLCharles River2026-08-05 11:00 EST

Charles River Laboratories Announces Second-Quarter 2026 Results

CRLCharles River2026-07-15 12:00 EST

Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call

CRLCharles River2026-07-13 12:00 EST

Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

CRLCharles River2026-06-18 12:00 EST